register

Medical and Science

The Gut-Brain connection

Health Industry Hub | September 4, 2019 |

For centuries, treating neurological conditions meant developing therapies or drugs that directly targeted the brain. Today the evidence argues that research, drugs, and therapy should actually focus on the gut.

The gut and brain have a unique connection that allows for communication past the brain’s main line of defense – the blood brain barrier. Many molecules that cross over the blood brain barrier are created by the gut microbiome, meaning that the brain and gut directly influence one another.

Watch the fascinating video to learn how the gut-brain pathway may lead us to discover causes behind, and even treatments for, life-altering conditions like Autism Spectrum Disorder and Parkinson’s Disease. By understanding communication between the gut and the brain, we may be able to change the course of neurological disease for generations.

About Sarkis Mazmanian

Medical microbiologist Sarkis K. Mazmanian is leading research into how the gut microbiome impacts and communicates with the immune and nervous systems. His work is specifically focused on how this two-way internal communication highway, known as the “gut-brain axis,” influences complex diseases of the brain, such as Parkinson’s and Alzheimer’s diseases. Sarkis has received numerous awards including the MacArthur Foundation “Genius” award and Discover Magazine’s “Best Brains in Science.” Currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering at the California Institute of Technology, Sarkis is also a founder of two biotech companies and the proud mentor of countless students and postdoctoral fellows who have gone on to successful independent careers in medicine, industry, and academia.

You may also like Australian researchers reveal new insights into retina’s genetic code


News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.